Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled Study to Investigate the Impact of Diamyd® on the Diabetes Status of Patients With LADA (Latent Autoimmune Diabetes in Adult)

NCT00456027 is registered in ClinicalTrials.gov with Diamyd Therapeutics AB as lead sponsor.

NCT NCT00456027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00456027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled Study to Investigate the Impact of Diamyd® on the Diabetes Status of Patients With LADA (Latent Autoimmune Diabetes in Adult)
Lead sponsor
Diamyd Therapeutics AB
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
April 30, 2008
Enrollment
160 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

latent autoimmune diabetes in adult (lada)